MENU
LCTX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases... Show more

A.I. Advisor
published Earnings

LCTX is expected to report earnings to rise 43.00% to -2 cents per share on August 07

Lineage Cell Therapeutics LCTX Stock Earnings Reports
Q2'25
Est.
$-0.03
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.02
The last earnings report on May 13 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 241.37K shares outstanding, the current market capitalization sits at 154.19M.
View a ticker or compare two or three
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
75
Web
https://www.lineagecell.com